http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#Head
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#assertion
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#provenance
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#pubinfo
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#assertion
http://purl.obolibrary.org/obo/DOID_643
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_643
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00108
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#association
http://www.w3.org/2000/01/rdf-schema#label
"TYSABRI is contraindicated in patients who have or have had progressive multifocal leukoencephalopathy (PML) [ see Warnings and Precautions ( 5.1 TYSABRI is contraindicated in patients who have had a hypersensitivity reaction to TYSABRI. Observed reactions range from urticaria to anaphylaxis [ see Warnings and Precautions ( 5.5 Patients who have or have had PML ( 4 Patients who have had a hypersensitivity reaction to TYSABRI ( 4 5.3"
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB00108
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#provenance
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#pubinfo
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#sig
http://purl.org/nanopub/x/hasSignature
R4T2SEtGuVb24myLUO3eSALoW54ZfhlDIARy2faNb7byEPwjVxLmtUz3FVQu2lfxayBscE337dyU1ci/YQDezmKn6NhUjNhieSwijGg/QTWOOvKu6ZSC9X65GyvnTu6W1VDdY0as+GnKgH7GbibR9qWWYaCy6GRnaOnbbPOrHCw=
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
http://purl.org/dc/terms/created
2021-08-23T18:31:53.513+02:00
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAoNfIJ6Ovo5Zrpxz_uiM4ntjjZOqYXBzesMMlwCo98n4
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY